✦ LIBER ✦

Recurrent hepatitis C after liver transplantation

✍ Scribed by Rosangela Teixeira; Sabrina Pastacaldi; George V. Papatheodoridis; Andrew K. Burroughs

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 155 KB
Volume: 61
Category: Article
ISSN: 0146-6615
DOI: 10.1002/1096-9071(200008)61:4<443::aid-jmv6>3.0.co;2-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histological recurrent hepatitis C after

Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation

✍ Giorgio Ercolani; Gian Luca Grazi; Matteo Ravaioli; Massimo Del Gaudio; Matteo C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

Impact of hepatitis C virus (HCV) recurrence on long-term outcome after orthotopic liver transplantation (OLT) is highly variable, and the role of retransplantation is still debated. From 1996 to 2003, 131 OLT with histologically proven HCV recurrence and 6 months of follow-up were retrospectively r

IgM anti-hepatitis C virus core antibodi

IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation

✍ Negro, Francesco; Giostra, Emiliano; Rubbia-Brandt, Laura; Mentha, Gilles; Coluc 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

The differential diagnosis of recurrent hepatitis C following orthotopic liver transplantation (OLT) may be difficult. We evaluated the diagnostic significance of IgM anti-hepatitis C virus (anti-HCV) core antibodies in 27 patients undergoing OLT because of HCV-associated cirrhosis. Serial serum sam

Antiviral treatment of recurrent hepatit

Antiviral treatment of recurrent hepatitis C after liver transplantation: The need for a multifaceted approach

✍ Didier Samuel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 1 views

## H epatitis C virus (HCV)-related cirrhosis is currently the leading indication for liver transplantation in Europe and in the United States. 1,2 HCV recurrence after transplantation is almost universal, and 60%-90% of patients will develop lesions of chronic hepatitis C on the graft. 3 The cour

Recurrent hepatitis C after liver transp

Recurrent hepatitis C after liver transplantation: On-treatment prediction of response to peginterferon/ribavirin therapy

✍ Ibrahim A. Hanouneh; Charles Miller; Federico Aucejo; Rocio Lopez; Mary Kay Quin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

Sustained virologic response (SVR) in the treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation (LT) remains suboptimal. We evaluated efficacy of pegylated interferon alfa (PEG) and ribavirin (RBV) (PEG/RBV) combination therapy in LT recipients with recurrent HCV and p

The significance of metabolic syndrome i

The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation

✍ Ibrahim A. Hanouneh; Ariel E. Feldstein; Arthur J. McCullough; Charles Miller; F 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

Although hyperinsulinemia and its associated metabolic syndrome (MS) have been implicated in the progression of hepatic fibrosis in hepatitis C virus (HCV) patients, little is known about the consequences of MS after orthotopic liver transplantation (OLT). The aim of this study was to assess the ass

The efficacy of prophylactic interferon

The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation

✍ Patricia A. Sheiner; Peter Boros; Franklin M. Klion; Swan N. Thung; Leona Kim Sc 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

Clinical recurrence of hepatitis C after liver transplantation can lead to cirrhosis, liver failure, and death. In patients undergoing liver transplantation for hepatitis C, we assessed the efficacy of interferon alfa-2b (IFN) in preventing recurrent hepatitis. We randomized 86 patients to either an